Google Cloud scores 6-year run with IDN reorienting toward tech-enabled patient experience

An integrated delivery network that covers five and a half million lives is bringing in Google Cloud to help build and maintain a patient-centric platform with advanced analytic and AI capabilities.

Pittsburgh-based Highmark Health is announcing the engagement will run for six years.

The organization, which has members in West Virginia and Delaware as well as Pennsylvania, says it’s looking to defragment the patient experience “with a more coordinated, personalized, technology-enabled” model.

It also wants to use data to unburden clinicians of administrative tasks and supply them with meaningful patient information.

Highmark Health will control access to the platform and, together with Google Cloud, form a review board to oversee data ethics and privacy.

Highmark says it’s creating around 125 new jobs to support the platform’s development. Most of the hires will be placed in application development, cloud-based computing architectures, analytics and user experience design.

Karen Hanlon, Highmark Health’s executive vice president and COO, says the organization arrived at this point after considering how the “entire health experience should be re-engineered with [patients] at the center. … [W]e had to change our organization by breaking down old paradigms and barriers, leveraging resources across our enterprise and bringing a differentiated approach to healthcare, which includes the development of a powerful technology platform to turbo-charge the model.”

Andrew Moore, VP of industry solutions at Google Cloud, adds that the “combination of Highmark Health’s deep understanding of patient behavior and clinical best practices with Google Cloud’s technology capabilities, including artificial Intelligence and machine learning expertise, will accelerate access to the most cutting-edge tools for people to improve their health.”

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.